Edwards Lifesciences Corporation EW reported fourth-quarter 2024 adjusted earnings per share (EPS) of 59 cents, which surpassed the Zacks Consensus Estimate by 7.3%. The figure increased 7.3% from the ...
Some results have been hidden because they may be inaccessible to you